130 related articles for article (PubMed ID: 448576)
1. Disposition of indomethacin in preterm infants.
Bhat R; Vidyasagar D; Vadapalli M; Whalley C; Fisher E; Hastreiter A; Evans M
J Pediatr; 1979 Aug; 95(2):313-6. PubMed ID: 448576
[TBL] [Abstract][Full Text] [Related]
2. Gestational age and indomethacin elimination in the neonate.
Evans MA; Bhat R; Vidyasagar D; Vadapalli M; Fisher E; Hastreiter A
Clin Pharmacol Ther; 1979 Dec; 26(6):746-51. PubMed ID: 498716
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of oral and intravenous indomethacin in preterm infants.
Bhat R; Vidyasagar D; Fisher E; Hastreiter A; Ramirez JL; Burns L; Evans M
Dev Pharmacol Ther; 1980; 1(2-3):101-10. PubMed ID: 6927543
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and disposition of indomethacin in preterm infants.
Friedman CA; Temple DM; Wender DF; Parks BR; Rawson JE
Dev Pharmacol Ther; 1991; 17(1-2):1-7. PubMed ID: 1811914
[TBL] [Abstract][Full Text] [Related]
5. Recovery of prostaglandin production associated with reopening of the ductus arteriosus after indomethacin treatment in preterm infants with respiratory distress syndrome.
Seyberth HW; Müller H; Wille L; Plückthun H; Wolf D; Ulmer HE
Pediatr Pharmacol (New York); 1982; 2(2):127-41. PubMed ID: 12760405
[TBL] [Abstract][Full Text] [Related]
6. Indomethacin and the preterm infant with a patent ductus arteriosus: relationship between plasma concentration and ductus closure.
Friedman CA; Parks BR; Rawson JE; Serwer GA; Anderson PA
Dev Pharmacol Ther; 1982; 4(1-2):37-46. PubMed ID: 7117089
[TBL] [Abstract][Full Text] [Related]
7. Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels.
O'Donovan DJ; Fernandes CJ; Nguyen NY; Adams K; Adams JM
Am J Perinatol; 2004 May; 21(4):191-7. PubMed ID: 15168317
[TBL] [Abstract][Full Text] [Related]
8. The disposition of indomethacin in preterm babies.
Yaffe SJ; Friedman WF; Rogers D; Lang P; Ragni M; Saccar C
J Pediatr; 1980 Dec; 97(6):1001-6. PubMed ID: 7441407
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of ibuprofen and indomethacin in preterm infants with patent ductus arteriosus.
Pacifici GM
Curr Pediatr Rev; 2014; 10(3):216-37. PubMed ID: 25088343
[TBL] [Abstract][Full Text] [Related]
10. Minimal effective dose of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
Dumas de la Roque E; Fayon M; Babre F; Demarquez JL; Pedespan L
Biol Neonate; 2002; 81(2):91-4. PubMed ID: 11844876
[TBL] [Abstract][Full Text] [Related]
11. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
[TBL] [Abstract][Full Text] [Related]
12. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
[TBL] [Abstract][Full Text] [Related]
13. Introduction of plasma indomethacin level monitoring and evaluation of an effective threshold level in very low birth weight infants with symptomatic patent ductus arteriosus.
Seyberth HW; Knapp G; Wolf D; Ulmer HE
Eur J Pediatr; 1983 Dec; 141(2):71-6. PubMed ID: 6363085
[TBL] [Abstract][Full Text] [Related]
14. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
[TBL] [Abstract][Full Text] [Related]
15. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
16. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
Chotigeat U; Jirapapa K; Layangkool T
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
[TBL] [Abstract][Full Text] [Related]
17. Variability of serum indomethacin concentrations after oral and intravenous administration to preterm infants.
Mrongovius R; Imbeck H; Wille L; Müller H; Seyberth HW
Eur J Pediatr; 1982 Mar; 138(2):151-3. PubMed ID: 7094936
[TBL] [Abstract][Full Text] [Related]
18. Closure of patent ductus arteriosus decreases pulmonary myeloperoxidase in premature infants with respiratory distress syndrome.
Varsila E; Hallman M; Venge P; Andersson S
Biol Neonate; 1995; 67(3):167-71. PubMed ID: 7640315
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus].
Seyberth HW; Müller H; Wille L; Plückthun H; Ulmer HE; Wolf D
Monatsschr Kinderheilkd; 1983 Feb; 131(2):71-6. PubMed ID: 6843560
[TBL] [Abstract][Full Text] [Related]
20. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome.
Van Overmeire B; Van de Broek H; Van Laer P; Weyler J; Vanhaesebrouck P
J Pediatr; 2001 Feb; 138(2):205-11. PubMed ID: 11174617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
